HeartSciences announced that the Centers for Medicare & Medicaid Services (CMS) have assigned reimbursement values for AI-ECG analysis services that include MyoVista technology, reducing the friction for U.S. health systems planning AI-ECG deployments.
Investor contact
Mark Komonoski, Integrous Communications · 877-255-8483 · investorrelations@heartsciences.com